Raltegravir, Tenofovir DF, and Emtricitabine for Postexposure Prophylaxis to Prevent the Sexual Transmission of HIV-Reference-Cited by-同舟云学术

Raltegravir, Tenofovir DF, and Emtricitabine for Postexposure Prophylaxis to Prevent the Sexual Transmission of HIV

Published:2012-04-01 Issue:4 Volume:59 Page:354-359
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Mayer Kenneth H.,Mimiaga Matthew J.,Gelman Marcy,Grasso Chris

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference29 articles.

1. . Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States.;Smith;MMWR Recomm Rep,2005

2. . Effectiveness of postinoculation (R)-9-(2-Phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.;Tsai;J Virol,1998

3. . Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).;Otten;J Virol,2000

4. . Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates.;Harrigan;Antimicrob Agents Chemother,2002

5. . Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.;Van Rompay;AIDS,1998

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and rates of infection by HIV in people receiving non-occupational post-exposure prophylaxis (nPEP) against HIV;Sexually Transmitted Infections;2024-05-13

2. Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies;Annals of Medicine;2023-12-08

3. Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions;The Lancet HIV;2023-12

4. Trends of nonoccupational postexposure prophylaxis in the United States;AIDS;2023-08-24

5. Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-05-01